Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance
Mitochondria are currently known as novel targets for treating cancer, especially for tumors displaying multidrug resistance (MDR). This present study aimed to develop a mitochondria-targeted delivery system by using triphenylphosphonium cation (TPP+)-conjugated Brij 98 as the functional stabilizer...
Main Authors: | Xue Han, Ruijuan Su, Xiuqing Huang, Yingli Wang, Xiao Kuang, Shuang Zhou, Hongzhuo Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | Asian Journal of Pharmaceutical Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087618303982 |
Similar Items
-
Mitochondria-targeted triphenylphosphonium-based compounds do not affect estrogen receptor α
by: Ludmila A. Zinovkina, et al.
Published: (2020-03-01) -
(Cyanomethyl)triphenylphosphonium chloride
by: Muhammad Shafiq, et al.
Published: (2008-11-01) -
(Furfurylamino)triphenylphosphonium bromide
by: Jean-Michel Grévy, et al.
Published: (2013-01-01) -
Adjudin-loaded redox-sensitive paclitaxel-prodrug micelles for overcoming multidrug resistance with efficient targeted Colon cancer therapy
by: Deli Chen, et al.
Published: (2020-01-01) -
pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer
by: He Wang, et al.
Published: (2021-05-01)